HSBC HOLDINGS PLC

Position in CCCC — C4 Therapeutics, Inc.

CIK 873630 LONDON, X0

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$63,647

+$27,803 QoQ

Shares Held

13,629

0.0% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#114

of 147 holders

Holding Since

Mar 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. CCCC ranks #121 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	676,247	$335,912,169
2	REGN	Regeneron Pharmaceuticals, Inc.	382,028	$238,209,735
3	INCY	Incyte Corp	1,307,743	$148,245,744
4	RPRX	Royalty Pharma plc	1,224,925	$68,681,542
5	MRNA	Moderna, Inc.	636,199	$44,553,014
6	ALNY	Alnylam Pharmaceuticals, Inc.	115,279	$34,702,435
7	INSM	INSMED Inc	279,961	$29,849,438
8	BMRN	Biomarin Pharmaceutical Inc	307,543	$17,597,610

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$63,647	13,629	0.0%	Shares	Defined	2026-08-14
2026-03-31	$35,844	13,629	0.0%	Shares	Defined	2026-04-30
2025-12-31	$26,031	13,629	0.0%	Shares	Defined	2026-03-06
2025-09-30	$30,256	13,629	-45.8%	Shares	Defined	2025-11-13
2025-06-30	$35,974	25,157	-1.3%	Shares	Defined	2025-08-13
2025-03-31	$40,779	25,487	+31.7%	Shares	Defined	2025-05-14
2024-12-31	$69,692	19,359	-8.5%	Shares	Defined	2025-02-14
2024-09-30	$120,657	21,168	-29.9%	Shares	Defined	2024-11-14
2023-12-31	$170,630	30,200	-7.5%	Shares	Defined	2024-02-12
2023-09-30	$60,734	32,653	0.0%	Shares	Defined	2023-11-13
2023-06-30	$89,795	32,653	+74.1%	Shares	Defined	2023-08-11
2023-03-31	$58,906	18,760	+84.7%	Shares	Defined	2023-05-15
2022-12-31	$59,914	10,155	-1.2%	Shares	Defined	2023-02-14
2022-03-31	$249,271	10,275	—	Shares	Defined	2022-05-16
No filing history on record for this holder in this stock.